A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer
Clinical trial NCT01617668 · COMPLETED
Trial details
- NCT number
- NCT01617668
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-09-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.